Literature DB >> 532858

Tubular carcinoma of the breast.

H A Oberman, W J Fidler.   

Abstract

Twenty-five patients with tubular carcinoma of the breast were reviewed. All of the lesions were small, averaging 0.9 cm in diameter, and none exceeded 2.0 cm in diameter. Regardless of treatment, the prognosis proved favorable. Only three of the patients manifested axillary lymph nodal metastases, and none died of recurrent or metastatic neoplasm. These neoplasms frequently were associated with intraductal carcinoma and, to a lesser extent, with lobular carcinoma in situ. It is concluded that tubular carcinoma represents a slow-growing expression of invasive mammary carcinoma; nevertheless, it is likely that, if inadequately treated, these lesions will evolve into more common patterns of invasive carcinoma.

Entities:  

Mesh:

Year:  1979        PMID: 532858

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Solid Tubular Carcinoma of the Breast: MR Imaging and Pathologic Correlation.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX.

Authors:  E R Fisher; A S Palekar; R Sass; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 3.  Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Authors:  D J Winchester; A A Sahin; S L Tucker; S E Singletary
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

4.  Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases.

Authors:  G N Peters; M Wolff; C D Haagensen
Journal:  Ann Surg       Date:  1981-02       Impact factor: 12.969

5.  Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Dae Bong Kim; Ye Ri Lee; Mi-Jung Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.